Pathway enrichment and FDA-approved drug repurposing analysis for the treatment of CTNNB1 Syndrome modeled in an SH-SY5Y cell line
Translation: The University of Toledo Journal of Medical Sciences is the online journal launched by the University of Toledo. Manuscripts will be considered on the understanding that they report original work and are not under consideration for publication by any other journal. The journal publishes original articles reporting experimental results of basic or clinical research, case reports, and reviews. The journal uses a single blind peer review system and each manuscript, based on the results presented in its original submission, will be evaluated by two student reviewers and one faculty reviewer. This process will provide an opportunity for medical students, graduate students, residents, fellows and faculty to publish research observation in a timely manner.
Authors
- Robert E. McCullumsmith (ORCID: https://orcid.org/0000-0001-6921-7150)
- John Vergis (ORCID: https://orcid.org/0009-0006-0864-3264)
Publication Details
- Journal
- Translation The University of Toledo Journal of Medical Sciences
- Published
- 2025-10-15
- DOI
- https://doi.org/10.46570/utjms-2025-1507
- Primary Topic
- Peptidase Inhibition and Analysis
- Type
- article
- Field-Weighted Citation Impact
- 0.00